Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 7, 2025Microbiology SpectrumOpen Access

Changes in Mycoplasma pneumoniae epidemiological and clinical features in children before, during, and after the COVID-19 pandemic in Shanghai, China

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSheng HuangWZWenfang ZhuangTXTing Xu

Discussion

Loading...

Member takes

Overview

Analysis reveals a significant rise in Mycoplasma pneumoniae infections among children post-NPIs, highlighting epidemiological changes.

Key Points

  • Significant increase in mycoplasma pneumoniae positivity rate observed in children after NPIs relaxed.
  • Annual positivity peaked at 56.32% in 2022, compared to 30.70% in 2020 during pandemic restrictions.
  • Hospitalized children showed varied clinical features, with notable changes in laboratory results across different phases.
  • Research underscores the implications of non-pharmaceutical interventions on respiratory infections in pediatric health.

Cite This Study

Huang et al. (2025) studied this question.

synapsesocial.com/papers/689dfe90d61984b91e13bc43https://doi.org/10.1128/spectrum.02888-24
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study2025
  2. 2Changing patterns of respiratory pathogens in hospitalized children with community-acquired pneumonia in northern China following the lifting of non-pharmaceutical interventions2025
  3. 3Epidemiology and Clinical Impact of Mycoplasma pneumoniae in an Italian Pediatric Center: An Observational Study from 2017 to 20242025 · 6 citations
  4. 4Positive rates of Mycoplasma pneumoniae antibodies in children before, during and after COVID-19 outbreak: an observational study in Chengdu, China from 2017 to 20242025
  5. 5Clinical epidemiology of community-acquired pneumonia in children before, during, and after the COVID-19 pandemic, and independent risk factors analysis for severe community-acquired pneumonia2025